Applied Therapeutics Inc (NASDAQ:APLT) currently has a daily average trading volume of 2.35M but it saw 4018300 shares traded in last market. With a market cap of 53.50M USD, the company’s current market price of $0.38 came falling about -13.23 while comparing to the previous closing price of $0.44. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.62 and as low as $0.29.
UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on December 02, 2024 while assigning a price target range of $13-$2. RBC Capital Mkts also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $12 and $4.
Over the week, APLT’s stock price is moving -22.11% down while it is 9.85% when we observe its performance for the past one month. Year-to-date it is -55.86% down and over the past year, the stock is showing a downside performance of -90.98%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.17 while estimate for next year EPS is -0.57. In next quarter, company is expected to be making quarterly sales of $416.67k as analysts are expecting the sales for current fiscal year at $1.25M and seeing the company making $29.02M in sales next year. Moreover, analysts are in estimates of $416.67k for current-quarter revenue.
Currently, Applied Therapeutics Inc’s total number of outstanding shares is 141.58M with 4.90% of that held by the insiders while 83.01% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -111.73% and return on equity (ROE) at -83.71%. Stock’s beta reads 1.91. Stock has a price to book (P/B) ratio of 1.46 while price to sale or P/S ratio amounts to 198.15. Its return on asset (ROA) is -41.81% on average.
